Life Sciences
Asia-Pacific Guide 2024 : Japan
Band 3
Email address
[email protected]Contact number
+81 3 6250 6200About
Provided by Nishimura & Asahi
Our Life Science and Healthcare Group offers a variety of legal services to domestic and international clients, including advising on issues regarding licensing, approvals, notifications, etc., compliance, risk management raised by non-compliance, defective product recalls, and information management and intellectual property rights in the medical field, healthcare field (including food and beverage fields), and the medicine and medical device fields, based on applicable laws such as the Pharmaceuticals Medical Machinery, etc. Act, the Medical Care Act, the Medical Practitioners Act, the Food Sanitation Act, and the Health Promotion Act. In addition, our Life Science and Healthcare Group has undertaken various M&A cases, taking advantage of the group’s broad knowledge, and provided strategic advice. We provide advice on a broad range of cases, including business mergers, joint ventures, acquisitions, and restructuring among pharmaceutical companies and medical device companies. As one example, we have advised Takeda Pharmaceutical Co., Ltd., the largest pharmaceutical company in Asia, on its transaction to acquire all of the issued and to-be-issued ordinary share capital of Shire plc, a Jersey-registered and Dublin, Ireland-headquartered global specialty biopharmaceutical company.
Chambers Review
Nishimura & Asahi has a well-established practice assisting an international roster of pharmaceutical and medical device companies, as well as academic institutions and major distributors. The firm is especially known for covering cross-border M&A, joint ventures and restructuring matters, alongside advice on regulatory matters and clinical trials. It ably handles IP rights, licensing and compliance issues in the life sciences space and represents clients in contentious matters such as patent infringement disputes. Its key clients include Toyota Tsusho, Bain Capital Private Equity and ORIX.
Work Highlights
- Nishimura & Asahi advised BPEA EQT on the sale of its shares in Bushu Pharmaceuticals to KKR.
Strengths
Provided by Chambers
"The range of expertise within the firm is broad, and even in highly specialised projects in the biotechnology field I feel that both their level of specialised knowledge and their speed and accuracy in grasping the situation are very strong."
"We receive accurate advice based on a thorough understanding of the industry environment in which our company is located."
"The range of expertise within the firm is broad, and even in highly specialised projects in the biotechnology field I feel that both their level of specialised knowledge and their speed and accuracy in grasping the situation are very strong."
"We receive accurate advice based on a thorough understanding of the industry environment in which our company is located."
Notable Practitioners
Mariko Mimura leverages her former role for the Japan branch of a major global pharmaceutical company and is well known for her expertise in handling pharmaceutical regulatory matters.
"I think she's one of the top lawyers in the industry."
"She provides valuable advice based on her corporate experience."
Ranked Lawyers at
Nishimura & Asahi
Japan
Members
Provided by Nishimura & Asahi
Gaku Suzuki
Hiroko Shibata
Mariko Mimura
Taisuke Igaki
Takahiko Date
Yoko Kasai
Yuki Oi